Actos Injuries - Bladder Cancer
The U.S. Food and Drug Administration (FDA) has issued warnings regarding the diabetes medicine Actos (pioglitazone). The FDA has found after an extensive study on Actos that when the drug is used for more than one year may be associated with an increased risk of bladder cancer. Longer use and higher dosages come with the greatest risks.
Based upon a French study, use of Actos has been suspended in France. Actos despite the noted risk has yet to be banned in the United States. The FDA is careful to state that it has yet to be conclusively determined that Actos causes bladder cancer. However, should the French study prove accurate, the health implications will be significant.
Actos is approved for the treatment and typically prescribed for Type 2 diabetes. However, the medicine like many medicines has on occasion been marketed for off-label uses as well.
The potential public health issues from Actos usage is significant. The FDA reports that just during the period from January 2010 through October 2010, approximately 2.3 million patients filled a prescription for Actos or other products containing pioglitazone. Actos was first approved by the FDA in 1999 so the numbers of users and potential victims of Actos risks could be staggering.
Again, according to the FDA, the offending ingredient pioglitazone is typically sold as the single ingredient product Actos. However, it is also sold in combination with metformin in the products Actoplus Met and Actoplus Met XR. It is also sold in combination with glimepiride under the trade name Duetact.
If you have taken any of these medications for more than one year, you should be alert to any signs of bladder cancer. If you have any signs of bladder cancer or concerns in general about the use of Actos, you should see your doctor immediately.
If you have been taking Actos for more than one year, and you now have bladder cancer, you may have a claim against the manufacturer Takeda. If you have a history of bladder cancer and have been placed on Actos by your doctor and have suffered a recurrence of bladder cancer, you may have a claim against both Takeda and your doctor for medical malpractice. In either case, you should consult with an experienced personal injury attorney immediately to protect your rights.
Based upon a French study, use of Actos has been suspended in France. Actos despite the noted risk has yet to be banned in the United States. The FDA is careful to state that it has yet to be conclusively determined that Actos causes bladder cancer. However, should the French study prove accurate, the health implications will be significant.
Actos is approved for the treatment and typically prescribed for Type 2 diabetes. However, the medicine like many medicines has on occasion been marketed for off-label uses as well.
The potential public health issues from Actos usage is significant. The FDA reports that just during the period from January 2010 through October 2010, approximately 2.3 million patients filled a prescription for Actos or other products containing pioglitazone. Actos was first approved by the FDA in 1999 so the numbers of users and potential victims of Actos risks could be staggering.
Again, according to the FDA, the offending ingredient pioglitazone is typically sold as the single ingredient product Actos. However, it is also sold in combination with metformin in the products Actoplus Met and Actoplus Met XR. It is also sold in combination with glimepiride under the trade name Duetact.
If you have taken any of these medications for more than one year, you should be alert to any signs of bladder cancer. If you have any signs of bladder cancer or concerns in general about the use of Actos, you should see your doctor immediately.
If you have been taking Actos for more than one year, and you now have bladder cancer, you may have a claim against the manufacturer Takeda. If you have a history of bladder cancer and have been placed on Actos by your doctor and have suffered a recurrence of bladder cancer, you may have a claim against both Takeda and your doctor for medical malpractice. In either case, you should consult with an experienced personal injury attorney immediately to protect your rights.
CONTACT OUR LAW FIRM FOR A CASE REVIEW NOW!
Please feel free to contact our law firm by phone or by email for a free case review. We can be reached by phone at (505) 242-5958 or through our email contact form by clicking here!
Connect